Decitabine Injection shortage
To Be Discontinued 2 presentations · 1 manufacturers · first FDA posting Feb 20, 2026 · last update Feb 20, 2026
Manufacturers: Ingenus Pharmaceuticals LLC
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Decitabine, Injection, 50 mg (NDC 50742-430-01) | Ingenus Pharmaceuticals LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Feb 20, 2026 Updated Feb 20, 2026 Discontinued Feb 20, 2026 |
| Decitabine, Injection, 50 mg (NDC 68001-573-41) | Ingenus Pharmaceuticals LLC | To Be Discontinued | — | Labeler: BluePoint Laboratories; Discontinuation of the manufacture of the drug | Posted Feb 20, 2026 Updated Feb 20, 2026 Discontinued Feb 20, 2026 |